Gillette / McDermott / Elsevier Inc. / Gynecologic Oncology Group / MEDLINE / /
Country
United States / /
Currency
pence / / /
Event
FDA Phase / Product Issues / /
Facility
University of Pittsburgh Medical Center / Women's Hospital / University of North Carolina / Cleveland Clinic / Massachusetts General Hospital / M.D. Anderson Cancer Center / Chapel Hill / Clinic Foundation / / /
IndustryTerm
Literature search strategy / evidenced-based treatment algorithm / prevention of breast cancer / rare cancer cooperative network / Breast Cancer Prevention / /
MedicalCondition
disease confined / uterine disease / uterine serous papillary cancer / ovarian cancer / Uterine serous carcinoma / uterine carcinosarcoma / residual disease / invasive serous carcinoma / nodal metastasis / uterine serous papillary carcinoma / I carcinomas / Metastatic disease / uterine papillary serous cancer / endometrial carcinomas / relatively rare endometrial carcinoma / endometrial carcinoma / papillary serous and clear cell endometrial cancers / papillary serous endometrial carcinoma / serous epithelial ovarian carcinoma / several other cancers / breast cancer / endometrial intraepithelial carcinoma / Uterine papillary serous carcinoma / gross metastatic disease / recurrent disease / papillary serous and clear cell carcinomas / intraepithelial carcinoma / adenocarcinoma / I endometrial carcinomas / Tumor / serous ovarian carcinoma / malignant tumors / endometrioid corpus cancers / Tubal (serous) carcinoma / measurable disease / cancer / tumors / gynecologic cancers / visible residual disease / gross residual disease / stage IVB disease / II carcinomas / intraabdominal disease / endometrial neoplasm / aggressive tumor / high-grade endometrial cancer / ovarian serous carcinoma / clear cell endometrial cancer / residual uterine disease / high-grade carcinoma / noted extrauterine disease / recurrent endometrial carcinoma / advanced-stage disease / IA disease / endometrioid carcinoma / rationale Endometrial cancer / high-grade carcinomas / atypical endometrial hyperplasia / High-grade endometrial carcinoma / prospective trials evaluating endometrioid adenocarcinoma / liver and endometrial cancer / IC disease / total tumor / advanced endometrial cancer / advanced-stage primary disease / loco-regional disease / advanced-stage cancers / stage IB/IC disease / post-operative residual disease / II endometrial carcinoma / local disease / serous carcinomas / Early-stage disease / J Cancer / recurrent endometrial cancer / endometrial cancers / colon cancer / II endometrial carcinomas / mixed component tumor / extrauterine disease / endometrial cancer / obesity / Women's Cancer / corpus cancer / endometrial carcinogenesis / advancedstage endometrial cancer / Kempson R. Uterine papillary serous carcinoma / maximal residual disease / IV endometrial carcinoma / disease / IV disease / tamoxifen-treated breast cancer / omental disease / residual cancer / uterine tumor / uterine neoplasm / subsequent breast cancers / hyperlipidemia / stage IIIC disease / hereditary breast-ovarian cancer syndrome / chronic grade / coincident extrauterine disease / EEC= endometrioid endometrial carcinoma / hereditary breast-ovarian cancer / advanced-stage endometrial carcinoma / positive invasive breast cancer / high-grade endometrial carcinomas / endometrial adenocarcinoma / morphologically diverse neoplasm / intraperitoneal metastases / stage IA disease / /
Department of Obstetrics / Gynecology and Reproductive Biology / Society for Gynecologic Oncologists / Gynecologic Oncologists Clinical Practice Committee / University of Pittsburgh / Pathology Committee / Cleveland Clinic Foundation / Pittsburgh Medical Center / SGO Council / International Federation of Gynecology and Obstetrics / Magee-Women's Hospital / Yawkey Center / University of North Carolina / Massachusetts General Hospital / USA Department of Obstetrics and Gynecology / International Federation of Gynecology / Society of Gynecologic Oncology / Van Le L. Association / Department of Obstetrics / Gynecology / and Reproductive Sciences / Division of Gynecologic Oncology / Clinical Practice Committee / /
Person
Amanda Nickles Fader / David M. Boruta II / Ben Arie / IC UPSC / Arch Pathol / Paola A. Gehrig / Jennifer Bethke / Alexander B. Olawaiye / Davis JR / Zheng W. Endometrial / Vincent Obstetrics / Mary Eiken / /
Gynecologic Oncology[removed]–153 Contents lists available at ScienceDirect Gynecologic Oncology j o u r n a l h o m e p a g e : w w w. e l s e v i e r. c o m / l o c a t e / y g y n o